Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1998-1-6
|
pubmed:abstractText |
Vascular hypertrophy may increase the blood pressure by its effect on vascular resistance. In this study, adenoviral gene transfer of IFN-beta was analysed in a porcine model of balloon injury to determine whether a secreted growth inhibitory protein might affect the regrowth of vascular smooth muscle cells (VSMC) in vitro and in arteries. An adenoviral vector encoding IFN-beta (ADV-IFN-beta) was constructed by homologous recombination between sub360 genomic DNA, an ADV 5 derivative with a deletion in the E3 region and a porcine IFN-beta expression plasmid. Its antiproliferative effect was analysed using cell proliferation assays, and used in a porcine model of balloon injury. After injury, arteries were immediately transfected with 7 x 10(9) plaques forming units of either ADV-IFN-beta or a control E1A deficient adenovirus that does not encode a recombinant protein, ADV-delta E1. The intima/media (I/M) area ratio was determined by quantitative morphometry 21 days after artery injury and gene transfer. Expression of recombinant porcine IFN-beta in VSMC reduced cell proliferation significantly in vitro, and supernatants derived from IFN-beta vector infected cells inhibited VSMC proliferation relative to controls. When introduced into porcine arteries after balloon injury, a reduction in I/M ratio of 30% was found. I/M ratio in the IFN-beta transduced arteries was 0.54 +/- 0.03 vs 0.69 +/- 0.06 in ADV-delta E1 transfected arteries and 0.702 +/- 0.05 in the non-transfected arteries. Gene transfer of an adenoviral vector encoding IFN-beta to VSMC and injured arteries reduced cell proliferation and vascular thickening. This approach is potentially applicable to vascular proliferative diseases.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0003-9683
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1121-5
|
pubmed:dateRevised |
2009-2-13
|
pubmed:meshHeading |
pubmed-meshheading:9404420-Animals,
pubmed-meshheading:9404420-Cell Division,
pubmed-meshheading:9404420-Cells, Cultured,
pubmed-meshheading:9404420-Disease Models, Animal,
pubmed-meshheading:9404420-Endothelium, Vascular,
pubmed-meshheading:9404420-Femoral Artery,
pubmed-meshheading:9404420-Gene Expression,
pubmed-meshheading:9404420-Gene Transfer Techniques,
pubmed-meshheading:9404420-Genetic Vectors,
pubmed-meshheading:9404420-Interferon-beta,
pubmed-meshheading:9404420-Muscle, Smooth, Vascular,
pubmed-meshheading:9404420-Muscle Development,
pubmed-meshheading:9404420-Swine,
pubmed-meshheading:9404420-Transfection
|
pubmed:year |
1997
|
pubmed:articleTitle |
[Gene transfer of interferon beta inhibits vascular smooth muscle cell proliferation in vitro and in animal model of arterial injury].
|
pubmed:affiliation |
Institut de pharmacologie, université Louis-Pasteur, Strasbourg.
|
pubmed:publicationType |
Journal Article,
In Vitro,
English Abstract,
Research Support, Non-U.S. Gov't
|